National Research Corporation (NRC), dba NRC Health, announced that its Board of Directors authorized a stock repurchase program of up to $60M of the company’s outstanding common stock through March 31, 2028.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRC: